Two major news stories about breast cancer were announced this week, and two Georgia Cancer Specialists (GCS) physicians—Dr. Mansoor Saleh and Dr. Lynn Zemsky—appeared on two Atlanta TV news stations to explain the findings.
On Monday, February 25, Dr. Mansoor Saleh, the director of clinical research at GCS, was interviewed on CBS Atlanta about the FDA approval of the breast cancer drug T-DM1, which extends the survival of women with HER2+ advanced breast cancer. GCS was a proud participant in the study. See the interview below.
On Wednesday, February 27, Dr. Lynn Zemsky spoke with WSB-TV about troubling new study results showing an increase in advanced breast cancer in younger women, ages 25-39, over the last three decades. To see the interview, click here.
Breast cancer is the second largest cause of cancer death among U.S. women, after lung cancer. It kills 500,000 people globally every year and is diagnosed in close to 1.3 million people around the world.
Georgia Cancer Specialists is a Top 10 private cancer practice in the U.S. and a leader in advanced cancer treatment and research. The practice supports more than 150,000 patient visits each year. GCS offers community-based medical oncology and hematology services and is the first private oncology practice to also provide a full range of support services for patients in Georgia. GCS physicians were the first in Georgia to offer Phase I clinical trials, the most novel cancer therapies available. GCS 46 medical oncologists practice in 27 locations in Metro Atlanta, and North and Central Georgia. Georgia Cancer Specialists can be found on the web at www.gacancer.com. GCS is The Cancer Answer®.